Alejandro Alvarez, MD
Nephrology · Florissant, MONPI 1508846304
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Bard Peripheral Vascular, Inc. accounts for 87.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $49,594 and has fallen 85.2% since, to $7,359 in 2025. Among nephrology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 770 payments — averaging $228.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$154K
- Medtronic$11K
- C. R. Bard, Inc. & Subsidiaries$2K
- W. L. Gore & Associates, Inc.$2K
- Inari Medical, Inc.$2K
- Covidien LP$1K
- plus $3K from 23 others
What the payments were for
- Consulting fees$104,38059%
- Speaking & faculty fees$35,65020%
- Travel & lodging$15,3189%
- Food & beverage$20,27212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 491 | $154,192 |
| Medtronic | 123 | $10,619 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $2,300 |
| W. L. Gore & Associates, Inc. | 12 | $2,199 |
| Inari Medical, Inc. | 8 | $1,859 |
| Covidien LP | 53 | $1,163 |
| Venturemed Group, Inc. | 18 | $1,160 |
| Mozarc Medical US LLC | 27 | $630 |
| BD | 3 | $214 |
| Bard Access Systems, Inc. | 1 | $166 |
| Vifor Pharma, Inc. | 4 | $154 |
| C. R. Bard Foundation, Inc. | 1 | $140 |
| Argon Medical Devices, Inc. | 1 | $136 |
| GSK | 1 | $113 |
| Calliditas Therapeutics US Inc. | 1 | $101 |
| Boston Scientific | 5 | $93 |
| Outset Medical Inc | 1 | $75 |
| Cardiovascular Systems Inc. | 3 | $51 |
| AstraZeneca | 2 | $46 |
| Johnson & Johnson | 2 | $40 |
| Mindray DS USA, Inc. | 2 | $30 |
| Boehringer Ingelheim | 1 | $23 |
| Amgen | 1 | $19 |
| Merck | 1 | $18 |
| Davol Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Arjo Inc. | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WAVELINQ$60,021
- Argyle$4,767
- LUTONIX$2,868
- ELLIPSYS VASCULAR ACCESS SYSTEM$2,668
- CT THROMBECTOMY SYSTEM KIT$2,500
- COVERA$2,207
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$1,160
- FLOWTRIEVER CATHETER, S$1,000
- FLEX Vessel Prep System$943
- Product in Development$435
- GORE VIABAHN Endoprosthesis$150
- RESOLUTE ONYX$144
- Clot Management$136
- IN.PACT Admiral$126
- Chameleon$125
- GORE VIABAHN Endoprosthesis with Heparin$123
- Fluency Endovascular Stent Graft$122
- Palindrome$103
- TARPEYO$101
How this compares
$175,621 in reported general payments places this provider in the 95th percentile of 253 nephrology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,408 |
| Methylprednisolone | 15 | $64 |
| Lactulose | 11 | $37 |
| Prednisone | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Florissant
- Donovan PolackFlorissant$5K
- Derek LarsonCreve Coeur$605K
- Marcos RothsteinSaint Louis$350K
- Anuja JavaSaint Louis$240K
- Kevin MartinSt Louis$189K
- Gary SingerSaint Peters$170K
- Daniel CoyneSaint Louis$163K
- Tarek AlhamadSaint Louis$155K
- Tingting LiSaint Louis$130K
- Bahar BastaniSt Louis$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.